Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Neurobiology of Aging|April 6, 2012
Serum leptin and cognitive function in people with type 2 diabetesJavier Labad, Jacqueline F Price, Mark W J Strachan, et al.
Lancet (London, England)|July 19, 2018
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trialsPeter M Rothwell, Nancy R Cook, J Michael Gaziano, et al.
Intelligence|November 13, 2009
Intelligence and persisting with medication for two years: Analysis in a randomised controlled trialIan J Deary, Catharine R Gale, Marlene C W Stewart, et al.
Health Technology Assessment (Winchester, England)|July 28, 2015
A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS)Fay Crawford, Genevieve Cezard, Francesca M Chappell, et al.
American Journal of Epidemiology|December 17, 2005
Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery StudyIoanna Tzoulaki, Gordon D Murray, Jacqueline F Price, et al.
Lancet (London, England)|March 24, 2012
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trialsPeter M Rothwell, Jacqueline F Price, F Gerald R Fowkes, et al.
JAMA|March 4, 2010
Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trialF Gerald R Fowkes, Jacqueline F Price, Marlene C W Stewart, et al.
Circulation. Cardiovascular Genetics|August 16, 2015
Functional Analysis of a Carotid Intima-Media Thickness Locus Implicates BCAR1 and Suggests a Causal VariantFreya Boardman-Pretty, Andrew J P Smith, Jackie Cooper, et al.
Cardiovascular Diabetology|August 24, 2016
Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acidsKatherine E Beaney, Jackie A Cooper, Stela McLachlan, et al.
Disease Markers|May 2, 2017
Functional Analysis of the Coronary Heart Disease Risk Locus on Chromosome 21q22Katherine E Beaney, Andrew J P Smith, Lasse Folkersen, et al.
Pageof 4